Products - Arthritis | Topic | NICE

Showing 13 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Gout: diagnosis and management (NG219)
Product type:
Guidance
Programme:
NICE guideline
Published:
9 June 2022
Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus) (IPG727)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
1 June 2022
Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis (IPG726)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
25 May 2022
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs (TA768)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
2 February 2022
Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs [ID1399]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
13 July 2022
Upadacitinib for treating active ankylosing spondylitis [ID3848]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
17 August 2022
Tofacitinib for treating active ankylosing spondylitis [ID3865]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
17 August 2022
Osteoarthritis: care and management (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
19 October 2022
Upadacitinib for treating active non-radiographic axial spondyloarthritis [ID3958]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
31 January 2023
GID-MT570 AposHealth for osteoarthritis (OA) of the knee
Status:
In development
Programme:
Medical technologies guidance
Expected publication date:
31 March 2023
Radiofrequency denervation for osteoarthritic knee pain
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
29 June 2023
Baricitinib for treating juvenile idiopathic arthritis in children and young people aged 1 to 17 TS ID 10662
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
GID-MT575 GaitSmart rehabilitation exercise programme
Status:
In development
Programme:
Medical technologies guidance
Expected publication date:
TBC